Brind.

Collaboration revenue streams are shared between Sanofi and Gilead Sciences.

1 report, 1 independent Updated Aug 12

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Sanofi Gilead Sciences

Keep exploring

The entities involved

Sanofi
French pharmaceutical company
- AbbVie and others are managing drug exclusivity, seeking next-gen immunology pipeline growth, and competing for market share.Thu 23:18
Gilead Sciences
American company
- Amgen and Gilead Sciences are two companies that compete within the biotech industry.Sun 11:22
- Gilead Sciences is commercializing medicines in Europe, with Anu Osinusi as VP of Clinical Development and Cynthia Levy supporting IDEAL results for Livdelzi.Fri 16:08

Related events

Sanofi, Hoffmann-La Roche, Gilead, and Pfizer announced a collaboration to co-develop bexobrutideg, with Sanofi providing a $10M milestone payment.Oct 12

Coverage

Newest first; wire copies grouped

Aug 12fool.com